Therapeutic Perspectives in the Systemic Treatment of Kaposi’s Sarcoma - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2022

Therapeutic Perspectives in the Systemic Treatment of Kaposi’s Sarcoma

Résumé

In patients with Kaposi’s sarcoma (KS), the therapeutic goal is to achieve a durable remission in the size and number of skin and visceral lesions. Although most patients show tumor regression in response to standard systemic chemotherapy regimens, alternative systemic treatments are needed for patients who develop refractory KS. Anti-angiogenic therapies represent attractive therapeutic targets in this context, due to the central role of angiogenesis in KS pathogenesis. Pomalidomide, which exhibits such anti-angiogenic activity through inhibition of VEGF, currently constitutes the most promising agent of this class and has been recently approved by the FDA. In addition, immune checkpoint blockade also represents an interesting alternative therapeutic approach through the restoration of immunity against HHV-8, the causative agent of KS, and improvement of tumor control. Although small series of cases treated successfully with these drugs have been reported, there is no marketing approval for anti-immune checkpoint antibodies for KS to date. In the present review, we will discuss potential therapeutic options for patients with recurrent or refractory KS, including systemic chemotherapies, immune checkpoint inhibitors, anti-herpesvirus agents, and anti-angiogenic drugs. Well-conducted clinical trials in this population are urgently needed to correctly address the efficacy of targeted agents and immunomodulators, while monitoring for adverse effects.
Fichier principal
Vignette du fichier
cancers-14-00484-v2.pdf (367.37 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03577127 , version 1 (16-02-2022)

Licence

Paternité

Identifiants

Citer

Marc-Antoine Valantin, Léna Royston, Maxime Hentzien, Aude Jary, Alain Makinson, et al.. Therapeutic Perspectives in the Systemic Treatment of Kaposi’s Sarcoma. Cancers, 2022, 14 (3), pp.484. ⟨10.3390/cancers14030484⟩. ⟨hal-03577127⟩
344 Consultations
83 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More